The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Ege University
- Enrollment
- 55
- Locations
- 1
- Primary Endpoint
- Change in AMH Level
Study Overview
Brief Summary
The aim of our study is to compare the effect of laparoscopic ovarian cystectomy on ovarian reserve in terms of different cyst types.
Detailed Description
Participants who will be treated surgically for ovarian cysts will be included in the study. Anti-Mullerian Hormone (AMH) levels of the participants will be investigated before the surgery and 6 months after the surgery. All surgeries will be performed under general anesthesia laparoscopically. After histopathological evaluation, the participants will be divided into three groups; Group 1: Endometrioma, Group 2: Mature cystic teratoma (Dermoid cyst) and Group 3: Serous or mucinous cystadenoma.
A total of fifty-five women will be included in the study.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 40 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •no ovarian surgery before
Exclusion Criteria
- •Endocrinological pathologies
- •Suspicion of malignancy in preoperative laboratory and ultrasonographic evaluations
- •Detection of malignancy in histopathological examination
Arms & Interventions
Endometrioma
Participants who will have endometrioma after histopathological evaluation.
Intervention: Laparoscopic cystectomy (Procedure)
Mature cystic teratoma (dermoid cyst)
Participants who will have mature cystic teratoma (dermoid cyst) after histopathological evaluation.
Intervention: Laparoscopic cystectomy (Procedure)
Serous or mucinous cystadenoma
Participants who will have serous or mucinous cystadenoma after histopathological evaluation.
Intervention: Laparoscopic cystectomy (Procedure)
Outcomes
Primary Outcomes
Change in AMH Level
Time Frame: 6 months
AMH levels of the participants will be investigated before the surgery and 6 months after the surgery.
Secondary Outcomes
No secondary outcomes reported
Investigators
Sabahattin Anıl Arı
Principal Investigator
Ege University
